Cargando…
Managing the dose escalation of biologics in an era of cost containment: the need for a rational strategy()()
Although biologic medications have demonstrated great efficacy for the treatment of psoriasis, a subset of patients fails to respond and others lose response later in the course. In treating a patient who has failed to respond to biologic therapy, clinicians must decide between dose escalation, swit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419024/ https://www.ncbi.nlm.nih.gov/pubmed/28492030 http://dx.doi.org/10.1016/j.ijwd.2016.09.003 |